Clinical Trial Update: A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating ongoing long-term Phase 2/Phase 3 studies of ALKS 2680 for narcolepsy types 1 and 2 and idiopathic hypersomnia, with recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia
• Narcolepsy Type

Drugs mentioned

• ALKS 2680

Snippet

Sponsor: Alkermes, Inc. | Conditions: Narcolepsy Type 1, Narcolepsy Type 2 | Phase 2, Phase 3 | Status: RECRUITING